This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by McClave, S. A. Articles by Heyland, D. K. Search for Related Content PubMed PubMed Citation Articles by McClave, S. A. Articles by Heyland, D. K. Pubmed/NCBI databases Medline Plus Health Information Nutritional Support Social Bookmarking                         What's this?

Nutrition Support in Acute Pancreatitis: A Systematic Review of the Literature

Stephen A. McClave, MD^*, Wei-Kuo Chang, MD, Rupinder Dhaliwal, RD and Daren K. Heyland, MD

From the ^* Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky; Tri-Service General Hospital, Taipei, Taiwan, Republic of China; and Queens University, Kingston, Ontario, Canada

Correspondence: Stephen A. McClave, MD, Professor of Medicine, Division of Gastroenterology/Hepatology, University of Louisville School of Medicine, Louisville, KY 40202. Electronic mail may be sent to Stephen.McClave{at}louisville.edu.

Background: Failure to use the gastrointestinal (GI) tract in patients with acute pancreatitis may exacerbate the stress response and disease severity, leading to greater incidence of complications and prolonged hospitalization. The objectives of this study were to determine the optimum route for nutrition support, whether nutrition therapy is better than no artificial nutrition support, whether specific additives to enteral or parenteral therapy can further enhance their efficacy, and whether methodologic differences in delivery of enteral nutrition (EN) influence tolerance. Methods: A computerized search was performed of MEDLINE, Cochrane database, EMBASE, and reference lists of pertinent review articles for prospective randomized trials in adult patients with acute pancreatitis that evaluated interventions with nutrition therapy. Primary outcome data and surrogate endpoint parameters (for nutrition indices, stress markers, and measures of the inflammatory/immune response) were extracted in duplicate independently. Where appropriate, meta-analysis was performed by random-effects model. Results: From 119 articles screened, 27 randomized controlled trials were included and analyzed. In patients admitted for acute pancreatitis, meta-analysis of 7 trials showed that use of EN was associated with a significant reduction in infectious morbidity (risk ratio [RR] = 0.46; 95% confidence interval [CI], 0.29 – 0.74; p = .001) and hospital length of stay (LOS; weighted mean difference [WMD] = –3.94; 95% CI, –5.86 to –2.02; p < .0001), a trend toward reduced organ failure (RR = 0.59; 95% CI, 0.28–1.27; p = .18), with no effect on mortality (RR = 0.88; 95% CI, 0.43–1.79; p = .72) when compared with use of parenteral nutrition (PN). Results from individual studies suggest that EN in comparison to PN reduces oxidative stress, hastens resolution of the disease process, and costs less. Insufficient data exist to determine whether EN improves outcome over standard therapy (no artificial nutrition support) in patients admitted for acute pancreatitis. However, in those patients requiring surgery for complications of acute pancreatitis, meta-analysis of 2 trials indicates that provision of EN postoperatively may reduce mortality (RR = 0.26; 95% CI, 0.06 – 1.09; p = .06) compared with standard therapy. PN provided early within 24 hours of admission was shown to worsen outcome, whereas PN provided later after full-volume resuscitation appeared to improve outcome when compared with standard therapy. In early individual studies, specific supplements added to EN, such as arginine, glutamine, -3 polyunsaturated fatty acids, and probiotics, may be associated with a positive impact on patient outcome in acute pancreatitis, compared with EN alone without the supplements, but studies are too few to make strong treatment recommendations. Supplementation of PN with parenteral glutamine was shown to reduce oxidative stress and improve patient outcome (reduced duration of nutrition therapy and decreased hospital LOS) compared with PN alone in patients with acute pancreatis. A wide range of tolerance to EN exists, irrespective of known influences such as mode (continuous vs bolus) and level of infusion within the GI tract (gastric vs postpyloric). Conclusions: Patients with acute severe pancreatitis should begin EN early because such therapy modulates the stress response, promotes more rapid resolution of the disease process, and results in better outcome. In this sense, EN is the preferred route and has eclipsed PN as the new "gold standard" of nutrition therapy. When PN is used, it should be initiated after 5 days. The favorable effect of both EN and PN on patient outcome may be further enhanced by supplementation with modulators of inflammation and systemic immunity. Individual variability allows for a wide range of tolerance to EN, even in severe pancreatitis.

Journal of Parenteral and Enteral Nutrition, Vol. 30, No. 2, 143-156 (2006)
DOI: 10.1177/0148607106030002143


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. A. McClave, D. K. Heyland, and P. E. Wischmeyer Comment On: Probiotic Prophylaxis in Predicted Severe Acute Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Trial JPEN J Parenter Enteral Nutr, July 1, 2009; 33(4): 444 - 446. [Abstract] [Full Text] [PDF]

				S. A. McClave and D. K. Heyland The Physiologic Response and Associated Clinical Benefits From Provision of Early Enteral Nutrition Nutr Clin Pract, June 1, 2009; 24(3): 305 - 315. [Abstract] [Full Text] [PDF]

				R. L. Koretz Enteral Nutrition: A Hard Look at Some Soft Evidence Nutr Clin Pract, June 1, 2009; 24(3): 316 - 324. [Abstract] [Full Text] [PDF]

				S. A. McClave, R. G. Martindale, V. W. Vanek, M. McCarthy, P. Roberts, B. Taylor, J. B. Ochoa, L. Napolitano, G. Cresci, the A.S.P.E.N. Board of Directors, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) JPEN J Parenter Enteral Nutr, May 1, 2009; 33(3): 277 - 316. [Full Text] [PDF]

				J. S. Simmons Postoperative Critical Care Management and Selected Postoperative Crises ACCP Crit Care Med Brd Rev, January 1, 2009; 20(0): 261 - 278. [Full Text] [PDF]

				J. W. Drover Nutritional Support in the Critically Ill Patient ACCP Crit Care Med Brd Rev, January 1, 2009; 20(0): 403 - 412. [Full Text] [PDF]

				C. Hurlock-Chorostecki Initial refeeding with a soft diet was better than a clear liquid diet for length of hospital stay in mild acute pancreatitis Evid. Based Nurs., January 1, 2009; 12(1): 22 - 22. [Full Text] [PDF]

				M. S. Petrov, H. C. van Santvoort, M. G. H. Besselink, G. J. M. G. van der Heijden, J. A. Windsor, and H. G. Gooszen Enteral Nutrition and the Risk of Mortality and Infectious Complications in Patients With Severe Acute Pancreatitis: A Meta-analysis of Randomized Trials Arch Surg, November 1, 2008; 143(11): 1111 - 1117. [Abstract] [Full Text] [PDF]

				E. Siow Enteral Versus Parenteral Nutrition for Acute Pancreatitis Crit. Care Nurse, August 1, 2008; 28(4): 19 - 30. [Full Text] [PDF]

				C. Fuentes-Orozco, G. Cervantes-Guevara, I. Mucino-Hernandez, A. Lopez-Ortega, G. Ambriz-Gonzalez, J. L. Gutierrez-de-la-Rosa, E. Gomez-Herrera, J. M. Hermosillo-Sandoval, and A. Gonzalez-Ojeda L-Alanyl-L-Glutamine-Supplemented Parenteral Nutrition Decreases Infectious Morbidity Rate in Patients With Severe Acute Pancreatitis JPEN J Parenter Enteral Nutr, July 1, 2008; 32(4): 403 - 411. [Abstract] [Full Text] [PDF]

				N. Y Carreazo, K. Ugarte, and C. Bada When should we start oral intake in children with severe acute pancreatitis? Evid. Based Nurs., April 1, 2008; 11(2): 39 - 40. [Full Text] [PDF]

				S. Mahadeva, A. Malik, I. Hilmi, C.-S. Qua, C.-H. Wong, and K.-L. Goh Transnasal Endoscopic Placement of Nasoenteric Feeding Tubes: Outcomes and Limitations in Non-Critically Ill Patients Nutr Clin Pract, April 1, 2008; 23(2): 176 - 181. [Abstract] [Full Text] [PDF]

				N. Y Carreazo P, K. Ugarte R, and C. Bada M When should we start oral intake in children with severe acute pancreatitis? Evid. Based Med., February 1, 2008; 13(1): 4 - 5. [Full Text] [PDF]

				W. C. Edmondson Nutritional support in critical care: an update CEACCP, December 1, 2007; 7(6): 199 - 202. [Full Text] [PDF]

				C. Alberda, L. Gramlich, J. Meddings, C. Field, L. McCargar, D. Kutsogiannis, R. Fedorak, and K. Madsen Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial Am. J. Clinical Nutrition, March 1, 2007; 85(3): 816 - 823. [Abstract] [Full Text] [PDF]

				A. Thomson Nutrition Therapy in Acute Pancreatitis JPEN J Parenter Enteral Nutr, November 1, 2006; 30(6): 536 - 537. [Full Text] [PDF]

				S. A. McClave and D. K. Heyland Letters to the Editor JPEN J Parenter Enteral Nutr, November 1, 2006; 30(6): 537 - 538. [Full Text]

				C. W. Van Way III Perioperative Immunonutrition: Good Idea or More Hype? JPEN J Parenter Enteral Nutr, November 1, 2006; 30(6): 539 - 540. [Full Text] [PDF]